Last reviewed · How we verify

NCT05269732

CBT for Postpartum Depression and Infant Emotion Regulation

Active, enrolled NA Last updated 27 November 2024
What this trial tests

NA trial testing Group Cognitive Behavioural Therapy (CBT) in Postpartum Depression in 172 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
17 June 2022
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorMcMaster University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment172
Start date17 June 2022
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

McMaster University

Who can join

Adults 18 to 99, female only, with Postpartum Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to determine if online group cognitive behavioral therapy (CBT) for maternal postpartum depression (PPD) added to treatment as usual (TAU) leads to greater improvements in infant emotion regulation (ER) than maternal receipt of TAU alone immediately post-treatment and 6 months later. This study will also aim to determine what mechanisms PPD treatment leads to changes in infant ER.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Group Cognitive Behavioural Therapy (CBT)

Trials testing the same drug.

Other recruiting trials for Postpartum Depression

Currently open trials in the same condition.

Other McMaster University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05269732.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing